A new trading day began on Monday, with Edgewise Therapeutics Inc (NASDAQ: EWTX) stock price down -7.21% from the previous day of trading, before settling in for the closing price of $32.59. EWTX’s price has ranged from $6.44 to $38.12 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 5.38%. With a float of $62.41 million, this company’s outstanding shares have now reached $94.41 million.
Let’s look at the performance matrix of the company that is accounted for 88 employees. In terms of profitability, gross margin is 29.31%, operating margin of -6534.37%, and the pretax margin is -5519.27%.
Edgewise Therapeutics Inc (EWTX) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Edgewise Therapeutics Inc is 34.09%, while institutional ownership is 74.06%. The most recent insider transaction that took place on Sep 20 ’24, was worth 2,120,101. In this transaction Chief Scientific Officer of this company sold 75,000 shares at a rate of $28.27, taking the stock ownership to the 12,719 shares. Before that another transaction happened on Sep 20 ’24, when Company’s General Counsel sold 50,000 for $28.37, making the entire transaction worth $1,418,510. This insider now owns 3,252 shares in total.
Edgewise Therapeutics Inc (EWTX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 5.38% per share during the next fiscal year.
Edgewise Therapeutics Inc (NASDAQ: EWTX) Trading Performance Indicators
Here are Edgewise Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 26.35.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.49, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.83 in one year’s time.
Technical Analysis of Edgewise Therapeutics Inc (EWTX)
Edgewise Therapeutics Inc (NASDAQ: EWTX) saw its 5-day average volume 0.79 million, a negative change from its year-to-date volume of 0.93 million. As of the previous 9 days, the stock’s Stochastic %D was 40.25%. Additionally, its Average True Range was 1.81.
During the past 100 days, Edgewise Therapeutics Inc’s (EWTX) raw stochastic average was set at 65.89%, which indicates a significant increase from 13.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.48% in the past 14 days, which was lower than the 90.50% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $32.46, while its 200-day Moving Average is $21.87. Nevertheless, the first resistance level for the watch stands at $32.20 in the near term. At $34.16, the stock is likely to face the second major resistance level. The third major resistance level sits at $35.43. If the price goes on to break the first support level at $28.97, it is likely to go to the next support level at $27.70. Assuming the price breaks the second support level, the third support level stands at $25.74.
Edgewise Therapeutics Inc (NASDAQ: EWTX) Key Stats
With a market capitalization of 2.86 billion, the company has a total of 94,689K Shares Outstanding. Currently, annual sales are 0 K while annual income is -100,160 K. The company’s previous quarter sales were 0 K while its latest quarter income was -34,130 K.
